| |
 |
|
Class Information
Number: 548/537
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is five-membered consisting of one nitrogen and four carbons (e.g., halopyrrolidines, etc.) > Having -c(=x)-, wherein x is chalcogen, bonded directly to the five membered hetero ring (e.g., pyrrole carbonyl halides, pyrrole carboxaldehyde, etc.) > Acyclic nitrogen bonded directly to the -c(=x)- (e.g., 4,5-dihalopyrrole -2 carboxamides, etc.)
Description: Compounds wherein the group is bonded directly to acyclic nitrogen.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615647 |
Process for producing atorvastatin hemicalcium |
Nov. 10, 2009 |
| 7601753 |
Pyrrolidine melanocortin-specific compounds |
Oct. 13, 2009 |
| 7598400 |
AMPO spin traps |
Oct. 6, 2009 |
| 7592336 |
Hepatitis C virus inhibitors |
Sep. 22, 2009 |
| 7592365 |
Substituted pyrroles, compositions containing same, method for making same and use thereof |
Sep. 22, 2009 |
| 7589216 |
Process for preparing N-hydroxyformamido-propyl pyrrolidin compounds and intermediates |
Sep. 15, 2009 |
| 7579369 |
CB 1 receptor inverse agonists |
Aug. 25, 2009 |
| 7563911 |
Process for the preparation of amorphous atorvastin calcium salt (2:1) |
Jul. 21, 2009 |
| 7560571 |
Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof |
Jul. 14, 2009 |
| 7544714 |
Lipid-amino acid conjugates and methods of use |
Jun. 9, 2009 |
| 7538136 |
Crystalline forms of atorvastatin |
May. 26, 2009 |
| 7534810 |
Salt forms of [R--(R*,R*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H- -pyrrole-1-heptanoic acid |
May. 19, 2009 |
| 7511157 |
Hepatitis C inhibitor dipeptide analogs |
Mar. 31, 2009 |
| RE40667 |
[R-(R*R*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl-3-- phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
Mar. 17, 2009 |
| 7501450 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Mar. 10, 2009 |
| 7488750 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Feb. 10, 2009 |
| 7468444 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Dec. 23, 2008 |
| 7465806 |
Pyrrole-derivatives as factor Xa inhibitors |
Dec. 16, 2008 |
| 7456297 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Nov. 25, 2008 |
| 7446125 |
Derivatives of nitroproline compounds, processes of manufacture and uses in the treatment of integrin mediated disorders |
Nov. 4, 2008 |
| 7429613 |
Process for the preparation of atorvastatin and intermediates |
Sep. 30, 2008 |
| 7425576 |
Compounds as inhibitors of hepatitis C virus NS3 serine protease |
Sep. 16, 2008 |
| 7423058 |
Inhibitors of hepatitis C virus NS3 protease |
Sep. 9, 2008 |
| 7411075 |
Polymorphic form of atorvastatin calcium |
Aug. 12, 2008 |
| 7402683 |
Cinnamic acid amides |
Jul. 22, 2008 |
| 7396851 |
Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of .beta.-thalassaemia |
Jul. 8, 2008 |
| 7388017 |
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
Jun. 17, 2008 |
| 7388008 |
Lysine based compounds |
Jun. 17, 2008 |
| 7381727 |
Pyrrole derivatives, their preparation and their therapeutic use |
Jun. 3, 2008 |
| 7378409 |
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
May. 27, 2008 |
| 7361772 |
Process for the production of atorvastatin calcium |
Apr. 22, 2008 |
| 7342120 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Mar. 11, 2008 |
| 7342041 |
3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease |
Mar. 11, 2008 |
| 7329762 |
Prodrugs of mitotic kinesin inhibitors |
Feb. 12, 2008 |
| 7323490 |
Pyrrole compounds and uses thereof |
Jan. 29, 2008 |
| 7294644 |
CB 1 receptor inverse agonists |
Nov. 13, 2007 |
| 7276612 |
Hydroxamates as therapeutic agents |
Oct. 2, 2007 |
| 7265146 |
Integrin receptor inhibitors |
Sep. 4, 2007 |
| 7262202 |
Inhibitors of cyclin dependent kinases as anti-cancer agent |
Aug. 28, 2007 |
| 7256212 |
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
Aug. 14, 2007 |
| 7253204 |
Inhibitors of histone deacetylase |
Aug. 7, 2007 |
| 7230120 |
Amorphous HMG-CoA reductase inhibitors of desired particle size |
Jun. 12, 2007 |
| 7211601 |
Pharmaceutically active pyrrolidine derivatives |
May. 1, 2007 |
| 7208608 |
Method of manufacturing an amorphous form of the hemi-calcium salt of (3R,5R) 7-3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrro- l-1-yll-3, 5-dihydroxyheptanoic acid (actorvasta |
Apr. 24, 2007 |
| 7205330 |
Inhibitors of hepatitis C virus NS3 protease |
Apr. 17, 2007 |
| 7196112 |
Cell adhesion inhibitors |
Mar. 27, 2007 |
| 7193090 |
Preparation of atorvastatin |
Mar. 20, 2007 |
| 7189755 |
Pyrrolidine melanocortin-specific compounds |
Mar. 13, 2007 |
| 7189861 |
Processes for preparing amorphous atorvastatin hemi-calcium |
Mar. 13, 2007 |
| 7186735 |
Acylated arylcycloalkylamines and their use as pharmaceuticals |
Mar. 6, 2007 |
|
|
|
